Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament for treating inferior turbinate hypertrophy and method for preparing same

A drug and a hypertrophy technology, applied in the field of preparation of the drug, can solve the problems of affecting the function of the nasal cavity, long recovery time, dry nasal cavity, etc., and achieve the effects of easy recurrence, promotion of repair and remarkable curative effect.

Inactive Publication Date: 2010-10-06
胡学岚
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Surgical treatment will cause great damage to the hypertrophic mucosa of the inferior turbinate, postoperative swelling, pain, bleeding, dry nasal cavity, easy infection, long recovery time, and easy to cause nasal adhesion, which affects the function of the nasal cavity to varying degrees

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] The medicine of the present invention is made up of the following components (the amount is parts by weight): 10 parts of four flavors; 10 parts of ephedra; 6.5 parts of Xinyi; 5 parts of chicken roost; 6.5 parts of goose not food; 15 parts of fried xanthium; 7.5 parts; 6.5 parts of pangolin; 16.5 parts of angelica.

[0022] After the above-mentioned drugs are fully mixed, they are dried and crushed to 120 mesh; the powder is cured and sterilized at 100-110°C for 10-30 minutes; the powder after curing and sterilization is formulated in a weight ratio of 1:1 Compared with the moist burn ointment produced by Guangdong Shantou Meibao Pharmaceutical Co., Ltd., it is evenly blended and served.

Embodiment 2

[0024] The medicine of the present invention is made up of the following components (the amount is parts by weight): 18 parts of four flavors; 15 parts of ephedra; 10.5 parts of Xinyi; 10 parts of chicken roost; 10.5 parts of goose not food; 18 parts of fried xanthium; 11 parts; 10.5 parts of pangolin; 18.5 parts of angelica.

[0025] After the above-mentioned drugs are fully mixed, they are dried and crushed to 120 mesh; the powder is cured and sterilized at 100-110°C for 10-30 minutes; the powder after curing and sterilization is formulated in a weight ratio of 1:1 Compared with the moist burn ointment produced by Guangdong Shantou Meibao Pharmaceutical Co., Ltd., it is evenly blended and served.

Embodiment 3

[0027] The medicine of the present invention is made up of the following components (the amount is parts by weight): 20 parts of four flavors; 18 parts of ephedra; 12.5 parts of Xinyi; 12 parts of chicken roost; 12.5 parts of goose not food; 20 parts of fried cocklebur seeds; 13 parts; 12.5 parts of pangolin; 20.5 parts of angelica.

[0028] After the above-mentioned drugs are fully mixed, they are dried and crushed to 120 mesh; the powder is cured and sterilized at 100-110°C for 10-30 minutes; the powder after curing and sterilization is formulated in a weight ratio of 1:1 Compared with the moist burn ointment produced by Guangdong Shantou Meibao Pharmaceutical Co., Ltd., it is evenly blended and served.

[0029] The use method of the medicine of the present invention: use sterile cotton wool to make a cone-shaped cotton sliver of 8-10 cm in length, then evenly smear the medicine of the present invention on the tapered cotton sliver, gently send it into the nasal cavity with curve...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicament for treating inferior turbinate hypertrophy and a method for preparing the same. The medicament for treating the inferior turbinate hypertrophy consists of the following components in part by weight: 8 to 25 parts of musk, 10 to 20 parts of ephedra herb, 5 to 15 parts of biond magnolia flower, 5 to 15 parts of Chinese honeylocust fruit, 5 to 15 parts of sandwort, 10 to 25 parts of fried siberian cocklour fruit, 5 to 15 parts of euphorbia kansui, 5 to 15 parts of pangolin scales and 10 to 25 parts of Chinese angelica. The method comprises the following steps of: fully mixing the medicaments; drying and pulverizing the medicaments to be 120 meshes; boiling the powder at the temperature of between 100 and 110 DEG C and sterilizing the powder for 10 to 30 minutes; and adding moisture burn ointment in an amount which is equal to the weight of the sterilized powder into the sterilized powder and mixing the mixture uniformly. The medicament for treating the inferior turbinate hypertrophy has the advantages of economy, practicability, no use of oral medicament, no need of operation, injection or puncture, no bleeding, no pain, no damage to mucosa of nasal cavity; the patient needs not to stay in hospital and can go home immediately without affecting the work and study; and the medicament can also be used for treating chronic rhinitis, sinusitis and allergic rhinitis while treating the inferior turbinate hypertrophy.

Description

Technical field [0001] The invention relates to a medicine for treating inferior turbinate hypertrophy, specifically a Chinese patent medicine prepared by using Chinese herbal medicine as a raw material. The invention also relates to a preparation method of the medicine. Background technique [0002] Inferior turbinate hypertrophy refers to the turbinate mucosa edema caused by the inflammation of the turbinate for a long time, leading to nasal obstruction. The clinical manifestations include headache, dizziness, persistent nasal congestion, obstructive nasal sounds, snoring, tinnitus, irritability, decreased memory, and respiratory function Weakened, causing hypoxia in the brain. The prevalence of inferior turbinate hypertrophy in the population in my country is as high as 60%-70%, and about 800 to 900 million people suffer from various degrees of inferior turbinate hypertrophy. [0003] At present, there are three main methods for treating inferior turbinate hypertrophy at home a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/575A61P11/02A61K35/36A61K35/55
Inventor 胡学岚胡继刚
Owner 胡学岚
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com